These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 27701380)

  • 1. Identification of Helicobacter pylori and the evolution of an efficacious childhood vaccine to protect against gastritis and peptic ulcer disease.
    Blanchard TG; Czinn SJ
    Pediatr Res; 2017 Jan; 81(1-2):170-176. PubMed ID: 27701380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefits from elimination of Helicobacter pylori infection include major reduction in the incidence of peptic ulcer disease, gastric cancer, and primary gastric lymphoma.
    Graham DY
    Prev Med; 1994 Sep; 23(5):712-6. PubMed ID: 7845945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevalence of Helicobacter pylori in Japanese children with gastritis or peptic ulcer disease.
    Kato S; Nishino Y; Ozawa K; Konno M; Maisawa S; Toyoda S; Tajiri H; Ida S; Fujisawa T; Iinuma K
    J Gastroenterol; 2004 Aug; 39(8):734-8. PubMed ID: 15338366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring novel vaccines against Helicobacter pylori: protective and therapeutic immunization.
    Vyas SP; Sihorkar V
    J Clin Pharm Ther; 1999 Aug; 24(4):259-72. PubMed ID: 10475984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantifying the population impact of a prophylactic Helicobacter pylori vaccine.
    Rupnow MF; Shachter RD; Owens DK; Parsonnet J
    Vaccine; 2001 Dec; 20(5-6):879-85. PubMed ID: 11738753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The design of vaccines against Helicobacter pylori and their development.
    Del Giudice G; Covacci A; Telford JL; Montecucco C; Rappuoli R
    Annu Rev Immunol; 2001; 19():523-63. PubMed ID: 11244046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    Park KN; Hahm JS; Kim HJ
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospects for the development of a vaccine against Helicobacter pylori.
    Telford JL; Ghiara P
    Drugs; 1996 Dec; 52(6):799-804. PubMed ID: 8957151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Helicobacter pylori in peptic ulcer and gastric cancer].
    Matsukura N; Onda M; Yamashita K
    Gan To Kagaku Ryoho; 1995 Feb; 22(2):169-78. PubMed ID: 7857088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination of gnotobiotic piglets against Helicobacter pylori.
    Eaton KA; Ringler SS; Krakowka S
    J Infect Dis; 1998 Nov; 178(5):1399-405. PubMed ID: 9780261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection against Helicobacter pylori infection in BALB/c mice by oral administration of multi-epitope vaccine of CTB-UreI-UreB.
    Yang J; Dai LX; Pan X; Wang H; Li B; Zhu J; Li MY; Shi XL; Wang BN
    Pathog Dis; 2015 Jul; 73(5):. PubMed ID: 25846576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel chimeric flagellum fused with the multi-epitope vaccine CTB-UE prevents Helicobacter pylori-induced gastric cancer in a BALB/c mouse model.
    Song H; Lv X; Yang J; Liu W; Yang H; Xi T; Xing Y
    Appl Microbiol Biotechnol; 2015 Nov; 99(22):9495-502. PubMed ID: 26062531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral Immunization with a Multivalent Epitope-Based Vaccine, Based on NAP, Urease, HSP60, and HpaA, Provides Therapeutic Effect on
    Guo L; Yang H; Tang F; Yin R; Liu H; Gong X; Wei J; Zhang Y; Xu G; Liu K
    Front Cell Infect Microbiol; 2017; 7():349. PubMed ID: 28824883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of Helicobacter infection in children.
    Rowland M; Drumm B
    Br Med Bull; 1998; 54(1):95-103. PubMed ID: 9604435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helicobacter pylori vaccine strategies--triggering a gut reaction.
    Hatzifoti C; Wren BW; Morrow WJ
    Immunol Today; 2000 Dec; 21(12):615-9. PubMed ID: 11114421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helicobacter pylori vaccine development and use: a cost-effectiveness analysis using the Institute of Medicine Methodology.
    Rupnow MF; Owens DK; Shachter R; Parsonnet J
    Helicobacter; 1999 Dec; 4(4):272-80. PubMed ID: 10597398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epidemiology and clinical role of childhood Helicobacter pylori infection].
    Kato S
    Nihon Rinsho; 2001 Feb; 59(2):337-41. PubMed ID: 11218409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of Helicobacter pylori infection.
    Lee A
    Scand J Gastroenterol Suppl; 1996; 215():11-5. PubMed ID: 8722377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward the development of a stable, freeze-dried formulation of Helicobacter pylori killed whole cell vaccine adjuvanted with a novel mutant of Escherichia coli heat-labile toxin.
    Summerton NA; Welch RW; Bondoc L; Yang HH; Pleune B; Ramachandran N; Harris AM; Bland D; Jackson WJ; Park S; Clements JD; Nabors GS
    Vaccine; 2010 Feb; 28(5):1404-11. PubMed ID: 19897067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helicobacter pylori screening: options and challenges.
    Venerito M; Goni E; Malfertheiner P
    Expert Rev Gastroenterol Hepatol; 2016; 10(4):497-503. PubMed ID: 26619972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.